Stay updated on Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites by state (Arizona, California, Florida, Georgia, Illinois, Kansas, Minnesota, Montana, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Texas, Virginia, Washington, Wisconsin) and updated the revision tag from v3.3.2 to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-23T10:10:23.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Publications section updated: new PubMed-linked publications were added on 2025-11-20 and older PubMed entries were removed on 2025-09-02 and 2025-08-29. Entries are automatically populated from PubMed and may or may not pertain to the study.
    Difference
    0.1%
    Check dated 2025-11-24T19:06:20.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The site-wide government funding notice regarding potential updates and response delays was removed. This notice previously warned that information may not be up to date and that NIH operations could be affected.
    Difference
    0.2%
    Check dated 2025-11-17T18:07:30.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The observed changes are minor formatting adjustments that do not alter the study's core content (interventions, eligibility criteria, outcomes). To avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T12:48:22.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Update to version v3.2.0 and addition of a government operating status notice; removal of a specific resource topic and older version tag (v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T17:32:05.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T10:49:46.000Z thumbnail image

Stay in the know with updates to Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.